Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia.

Odenike OM, Alkan S, Sher D, Godwin JE, Huo D, Brandt SJ, Green M, Xie J, Zhang Y, Vesole DH, Stiff P, Wright J, Larson RA, Stock W
Clin Cancer Res. 2008 14 (21): 7095-101

PMID: 18981008 · PMCID: PMC4498482 · DOI:10.1158/1078-0432.CCR-08-1007

MeSH Terms (14)

Antibiotics, Antineoplastic Chromosome Aberrations Cohort Studies Core Binding Factors Depsipeptides Drug Evaluation Enzyme Inhibitors Female Histone Deacetylase Inhibitors Histone Deacetylases Humans Leukemia, Myeloid, Acute Male Middle Aged

Connections (1)

This publication is referenced by other Labnodes entities:

Links